Long-term glycemic control using polymer-encapsulated human stem cell–derived beta cells in immune-competent mice
Arturo J. Vegas(Boston Children's Hospital), Daniel G. Anderson(Massachusetts Institute of Technology), Dale L. Greiner(University of Massachusetts Chan Medical School), Karsten Olejnik(Boston Children's Hospital), Felicia W. Pagliuca(Harvard University), Róbert Langer(Massachusetts Institute of Technology), James J. McGarrigle(University of Illinois Chicago), Siddharth Jhunjhunwala(Massachusetts Institute of Technology), Omid Veiseh(Rice University), José Oberholzer(University Hospital of Zurich), Jennifer Hollister‐Lock(Joslin Diabetes Center), Erin Langan(University of Massachusetts Chan Medical School), Mads Gürtler(Harvard University), Jie Li(Qingdao University), Stephanie Aresta-Dasilva(Boston Children's Hospital), Matthew A. Bochenek(University of Illinois Chicago), Gordon C. Weir(Joslin Diabetes Center), Joshua C. Doloff(Bloomberg (United States)), Jeffrey R. Millman(Washington University in St. Louis), Michael Chen(AbbVie (United States)), Hok Hei Tam(Massachusetts Institute of Technology), Douglas A. Melton(Harvard Stem Cell Institute), Andrew Bader(Harvard–MIT Division of Health Sciences and Technology), Srujan Gandham(Boston Children's Hospital)
PMC
January 1, 2016
Cited by 0
Related Papers
Transdermal drug delivery
|Nature Biotechnology|2008|3.4k
Physical and mechanical properties of PLA, and their functions in widespread applications — A comprehensive review
|Advanced Drug Delivery Reviews|2016|3.2k
Knocking down barriers: advances in siRNA delivery
|Nature Reviews Drug Discovery|2009|3.1k
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
|Advanced Drug Delivery Reviews|2009|1.8k